Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx In Finance Cmte.: Will Graham-Snowe Replace Breaux-Frist?

Executive Summary

Sen. Graham (D-Fla.) is hoping to sign-up fellow Finance Committee member Snowe (R-Maine.) as a co-sponsor for a bipartisan Medicare outpatient prescription drug benefit bill.

You may also be interested in...



GPhA Endorses Graham Medicare Rx: Still Needs Finance Cmte. Republican

The Generic Pharmaceutical Association's endorsement of Sen. Graham's (D-Fla.) Medicare prescription drug bill makes GPhA the first pharmaceutical manufacturer trade association to sign on to a specific Medicare Rx bill.

GPhA Endorses Graham Medicare Rx: Still Needs Finance Cmte. Republican

The Generic Pharmaceutical Association's endorsement of Sen. Graham's (D-Fla.) Medicare prescription drug bill makes GPhA the first pharmaceutical manufacturer trade association to sign on to a specific Medicare Rx bill.

CBO Revised Medicare Rx Estimates Reduce Savings From PBM Techniques

The Congressional Budget Office is reducing its estimate for the savings impact from PBM cost management techniques under Rep. Thomas' (R-Calif.) Medicare prescription drug plan.

Related Content

UsernamePublicRestriction

Register

PS038078

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel